VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts News provided by Share this article Share this article AUSTIN, Texas, Feb. 2, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today provided a business update and announced the appointment of a new Chief Financial Officer, Mr. Terig Hughes, in addition to the appointment of Dr. Gaetan Michel as Chief Operating Officer, Mr. Gael Forterre as Chief Commercial Officer, and Dr. Mark Eccleston as Chief Technology Officer. A video providing a business update and introducing V...
Source: prnewswire.com